Kim Kardashian flies to Mexico for 'game-changing' health treatment
The 44-year-old reality star revealed that she left the US with her sister Khloé to undergo a cutting-edge stem cell treatment not currently available in the United States.
On Instagram, she shared photos from inside an austere-looking medical facility, dressed in black pajamas and dark goggles, posing with her doctor and even showing a moment mid-procedure, with what appeared to be blood on her back.
The treatment, called Muse stem cell therapy, is offered by Dr. Adeel Khan at Eterna Health.
According to the clinic, Muse cells can achieve 'complete cellular renewal' by replacing compromised cells with fully functional tissue in targeted areas like muscles or joints.
Kardashian said she first sought the therapy two years ago after tearing her shoulder while lifting weights, an injury that left her in 'debilitating pain.'
She claims that after the treatment, her shoulder recovered almost immediately, regaining full range of motion and eliminating the pain entirely.
Encouraged by that success, she returned to Mexico to address chronic back pain she says she had endured for years. Again, she reported immediate relief, describing the results as life-changing. S
he told her followers that if they struggle with similar pain, she 'can't recommend this treatment enough,' but was careful to add that every case is different, urging people to do their own research and consult medical professionals before pursuing it.
Muse stem cells are not banned in the United States, but the therapy is not approved for general use. The FDA only authorizes certain types of stem cell treatments – such as those using umbilical cord blood stem cells for blood disorders – while most others remain in the experimental phase.
This regulatory gap has led many patients seeking regenerative therapies to travel abroad, where clinics operate under different oversight standards. More Trending
However, Kardashian's post drew mixed reactions from the public. While some praised her openness in sharing her experience, others criticized the high cost (reportedly between $4,000 and $15,000 plus travel expenses) as a reminder that such breakthroughs remain out of reach for most people.
Her latest post highlights the growing interest in regenerative medicine, as well as the tension between innovation and accessibility in many areas of the medical field.
For now, Kardashian's experience is both a testament to the potential of emerging science and a reflection of the privilege needed to explore its benefits before they become mainstream.
Got a story?
If you've got a celebrity story, video or pictures get in touch with the Metro.co.uk entertainment team by emailing us celebtips@metro.co.uk, calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you.
MORE: Michael Bay leaves Will Smith Netflix film over 'creative differences'
MORE: Inside Kelly Clarkson and Brandon Blackstock's relationship as talent manager dies aged 48
MORE: Cassie Ventura returns to social media for first time since Diddy trial after giving birth
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
3 hours ago
- Metro
Nerve-racking moment politician suffers a stroke during live TV interview
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video A Serbian politician suffered a stroke on live television, shocking presenters as his face drooped and he began to slur his words. Minister for Public Investments Darko Glišićfell was a guest on Televizija Pink earlier this week when he began to stutter and act strangely. Worried, the two television presenters cut the broadcast short and called for an ambulance, which rushed him to the hospital in Belgrade. Glišićfell reportedly had surgery and is in serious condition, having been put on a ventilator briefly. The politician is close to President Alexander Vučić, who shared a photo of the pair in hospital on Instagram, captioned 'Courage, wait! There is no surrender.' Health Minister Zlatibor Loncar said in a statement: 'He fell ill during the TV show and was taken to the emergency room unconscious. What is known now is that he is in serious condition.' Strokes can affect anyone, old and young, and the symptoms can vary from person to person, but usually, they are very sudden. As different parts of your brain control different parts of your body, your symptoms will depend on the part of your brain affected and the extent of the damage. They occur when the blood supply to part of your brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. This means that within a few minutes, brain cells begin to die. Strokes aren't always life-threatening, but the earlier you get help for someone who you think may be suffering one, the better it is for them. Prompt treatment is crucial to minimise how much of brain damage and further complications the person is left with. S – Ask the person to SMILE T – Can they TALK? Ask if they can speak a simple sentence. R – See if they can raise both arms If they can't do any one of these, call 999. Not all sufferers share the same signs, according to the NHS. Other symptoms include complete paralysis of one side of the body sudden loss or blurring of vision confusion difficulty understanding what others are saying problems with balance and coordination difficulty swallowing (dysphagia) a sudden and very severe headache resulting in a blinding pain, unlike anything experienced before loss of consciousness. If you do experience these symptoms, it doesn't always mean it's a stroke. Symptoms of a stroke that disappear quickly and in less than 24 hours could be signs of a transient ischaemic attack (TIA). More Trending TIAs are like mini-strokes and usually last a few minutes or hours before disappearing altogether. A TIA means there isn't enough oxygen going to the brain. In its early stages, a TIA and a stroke look similar, so you should seek help either way. A TIA is also a warning that you may suffer a stroke in the future. Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page.
The Guardian
16 hours ago
- The Guardian
Pfizer Covid vaccine for young children may not be renewed by FDA
Pfizer's Covid vaccine for young children may not be renewed by the US Food and Drug Administration (FDA) this fall, prompting Moderna to fill possible gaps in supply, according to an email obtained by the Guardian. The move would pull the only remaining Covid vaccine for all children under five from the market. The Moderna vaccine is only approved for children with one or more health conditions, and the pediatric Covid vaccine from Novavax is only available for children aged 12 and up with health conditions. 'It certainly would create a hole in the availability of vaccines,' said Georges Benjamin, the executive director of the American Public Health Association. 'And to do it this late in the season – I think clearly it's inappropriate.' According to an email from the National Center for Immunization and Respiratory Diseases (NCIRD), Pfizer said the FDA recently informed the pharmaceutical company that it may not renew the emergency use authorization for its pediatric Covid vaccine for the 2025 respiratory season. The email was sent on Friday to state and local vaccination grantees. The Pfizer vaccine is given to children between the ages of six months and four years. Pfizer expects its Covid vaccine for children aged five to 11 to be fully licensed this fall, the email said. The Centers for Disease Control and Prevention (CDC) is 'in discussions' with Moderna about rapidly increasing its Covid vaccine supply for young children, according to the email. That includes internal planning about volume, timing, and potential supply gaps. 'We are working to ensure there will be sufficient supply,' said Chris Ridley, a Moderna spokesperson. The CDC, the US Department for Health and Human Services (HHS), and Pfizer did not respond to media inquiries by publication time. In July, Moderna received FDA approval of its Covid pediatric shot. But the vaccine was only approved for children with one or more health conditions that make them more vulnerable to Covid. This move could limit access to Covid vaccines. 'We already have a low number of people using the vaccines to start with,' Benjamin said. 'There hasn't been enough promotion of vaccinations for kids, and then you have Mr [Robert F] Kennedy's [Jr] unscientific statements about the safety and efficacy of vaccines, particularly Covid vaccines, for both pregnant women and kids. It has muddied the waters of what people know about the safety and efficacy of the vaccine.' The vaccine is extremely effective, especially against hospitalization and death. Yet only 5.6% of children aged six months to four years are vaccinated against Covid, and about 15% of children aged five to 17 are vaccinated, according to the CDC. While older adults have the highest rates of hospitalization and death, children continue seeing hospitalization rates from Covid similar to rates in 2020 and 2021. And there are other concerns with Covid infection. 'We don't know the long-term impact for kids who have gotten Covid as a disease. We do know it does cause a multi-systemic inflammatory process in a number of kids, which is very severe, and we don't know the long-term implications for long Covid in kids,' Benjamin said. Covid cases are rising in many parts of the US amid other vaccine restrictions proposed and implemented by health officials.
The Guardian
18 hours ago
- The Guardian
Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency. 'At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters. Prasad left the agency on 30 July after just a few months as director of the center. Endpoints News, which covers the biotech industry, first reported the return of Prasad. Prasad, an oncologist who was a fierce critic of US Covid-19 vaccine and mask mandates, was named the center's director by the FDA's commissioner, Marty Makary, in May. Criticism of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy (DMD) from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on 18 July to stop all shipments of the approved DMD therapy, saying it had safety concerns. The FDA changed course on Sarepta on 28 July and said shipments to the main group of patients for the drug could restart. Laura Loomer, a far-right influencer and conspiracy theorist with outsized sway over Donald Trump, had called Prasad a 'progressive leftist saboteur' who was undermining the agency's work. Two days before Prasad stepped down last month, Loomer had released misleadingly edited audio to suggest that that Prasad had admitted sticking pins in a Trump voodoo doll, when the full audio made it clear that he was talking about the kind of thing an imagined liberal Trump-hater would do. Loomer reacted to the news of Prasad's return on Saturday by renewing her attacks on him in a social media post in which she promised to produce 'exposes of officials within HHS and FDA' in the weeks ahead. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' she wrote. Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health. The FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of health secretary Robert F Kennedy Jr.
